Product
Infanrix hexa
1 clinical trial
1 indication
Indication
Pneumococcal InfectionsClinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Active-comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (PNEU-PED-EU-1)Status: Completed, Estimated PCD: 2021-08-05